Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies

被引:0
|
作者
Simpson, E. L. [1 ]
Boguniewicz, M. [2 ]
Thaci, D. [3 ]
Misery, L. [4 ]
Armstrong, A. W. [5 ]
Silverberg, J. I. [6 ]
Venturanza, M. E. [7 ]
Kallender, H. [7 ]
Gao, J. [7 ]
Szepietowski, J. C. [8 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Lubeck, Lubeck, Germany
[4] Univ Hosp Brest, Brest, France
[5] Univ Southern Calif, Los Angeles, CA 90007 USA
[6] George Washington Univ, Washington, DC USA
[7] Incyte Corp, Wilmington, DE USA
[8] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
675
引用
收藏
页码:E166 / E167
页数:2
相关论文
共 50 条
  • [21] Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kallender, Howard
    Sturm, Daniel
    Wang, Mingyue
    Eichenfield, Lawrence F.
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2139 - 2151
  • [22] Effects of ruxolitinib cream on sleep and quality of life over 52 weeks in black patients with atopic dermatitis
    Eichenfield, L. F.
    Gold, L. F. Stein
    Brar, K. K.
    Fuxench, Z. C. Chiesa
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S47 - S47
  • [23] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Kuligowski, Michael E.
    Kallender, Howard
    Sun, Kang
    Ren, Haobo
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1008 - 1016
  • [24] Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
    Papp, K.
    Szepietowski, J.
    Kircik, L.
    Toth, D.
    Eichenfield, L.
    Forman, S.
    Kuligowski, M.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S184 - S184
  • [25] Efficacy of ruxolitinib cream in patients with atopic dermatitis who demonstrated partial responses: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB50 - AB50
  • [26] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Armstrong, April W.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB149 - AB149
  • [27] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan L.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Micahel E.
    Venturanza, May E.
    Wei, Shaoceng
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 651 - 653
  • [28] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Thaci, Diamant
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB160 - AB160
  • [29] Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Papp, Kim
    Szepietowski, Jacek C.
    Blauvelt, Andrew
    Kircik, Leon
    Silverberg, Jonathan I.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Kallender, Howard
    Ren, Haobo
    Paller, Amy S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (04) : 669 - 683
  • [30] Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Boguniewicz, Mark
    Thaci, Diamant
    Misery, Laurent
    Silverberg, Jonathan I.
    Beck, Lisa A.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Szepietowski, Jacek C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121